Federated Hermes MDT Market Neutral ETF

MKTN · ETF

$28.48−$0.01 (−0.04%)TodayMarket closed ·
Prev close $28.49

About MKTN

MKTN was created on 2025-09-24 by Federated Hermes. The fund's investment portfolio concentrates primarily on long/short alternatives. MKTN utilizes a quantitatively-driven market neutral equity strategy, balancing long and short positions within the US equity market. The fund seeks long-term capital appreciation while limiting exposure to general stock market risk.

Issuer
Federated Hermes
Expense ratio
1.94%
Assets under management
$158.46M
Inception
Sep 24, 2025
Asset class
Alternatives

MKTN key statistics

Price-earnings ratio
0.00
Average volume
61.89K
Volume
267.81K
Open price
$28.53
High today
$28.53
Low today
$28.43
52 Week high
$29.07
52 Week low
$24.56

Federated Hermes MDT Market Neutral ETF (MKTN) at a glance

As of Oct 23, 2026, Federated Hermes MDT Market Neutral ETF (MKTN) shares are priced at $28.48, giving the company a price-to-earnings ratio of 0.00.

Today the fund has traded between $28.43 and $28.53. The current price is 0.2% above the day's low and 0.2% below its high.

Volume so far is 267.81K shares, above the average of 61.89K shares a day.

Over the past year Federated Hermes MDT Market Neutral ETF has ranged from $24.56 to $29.07, and now sits 87% of the way up that range.

MKTN news

  • Press releasePRNewswire

    Federated Hermes launches active ETF targeting high monthly distributions

  • Press releasePRNewswire

    Federated Hermes launches Federated Hermes MDT Market Neutral ETF

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.